Non-Small Cell Lung Cancer Market
According to Intent Market Research, the Non-Small Cell Lung Cancer Market is expected to grow from USD 25.1 Billion in 2024-e at a CAGR of 9.6% to touch USD 43.6 Billion by 2030. The Non-Small Cell Lung Cancer Market is dominated by key players such as, Bristol-Myers Squibb, Roche, Merck & Co., AstraZeneca, Eli Lilly, and Pfizer.